Local Navigation
Worldwide News
2008
- 24 DEC 2008
Otsuka Pharmaceutical Co., Ltd. to acquire Nutrition & Santé, the European market leader in functional and dietetic foods
- 6 OCT 2008
Galenea and Otsuka Pharmaceutical Extend & Expand Schizophrenia Research Collaboration
- 4 SEP 2008
Acucela and Otsuka Pharmaceutical Enter Co-Development Agreement for ACU-4429 in Dry Age Related Macular Degeneration
- 4 SEP 2008
Acucela and Otsuka Pharmaceutical Enter Co-Development Agreement for Rebamipide Ophthalmic Suspension for Dry Eye
- 3 SEP 2008
Deliver moisture into skin UL•OS Men's Skin Care Line from Otsuka Pharmaceutical Debuts September 9, 2008
- 28 AUG 2008
New addition to fruit soy bar SOYJOY 'plus' series lineup SOYJOY Orange Folic Acid Plus Debuts October 1, 2008
- 26 AUG 2008
Otsuka Pharmaceutical Co., Ltd. Makes Capital Investment to Acquire Interpharma Praha, Czech Republic
- 25 JULY 2008
Notice of the Reorganization of Three Otsuka Group Companies(Otsuka Pharmaceutical Factory, Otsuka Warehouse, and Taiho Pharmaceutical) as Wholly Owned Direct Subsidiaries
- 8 JULY 2008
Tatsuo Higuchi Appointed as President, Representative Director of Otsuka Holdings Co., Ltd.
- 8 JULY 2008
Establishment of Otsuka Holdings Co., Ltd.
- 26 JUNE 2008
Otsuka Pharmaceutical Co., Ltd. Announces the Appointment of New President
- 26 JUNE 2008
Otsuka Pharmaceutical Co., Ltd. Appoints the Board Members and Statutory Auditors
- 10 JUNE 2008
Otsuka and UCB agreed to co-develop and co-promote Keppra® and Cimzia® in Japan
- 28 MAY 2008
Otsuka Pharmaceutical Co., Ltd. invests in French leading mineral water company, ALMA S.A.
- 23 MAY 2008
(PDF) Otsuka Pharmaceutical Co., Ltd.- Fiscal Year through March 2008 – Parent Company Results
- 23 MAY 2008
(PDF) Otsuka Pharmaceutical Co., Ltd.-Fiscal Year through March 2008 – Consolidated Results
- 12 MAY 2008
Abilify®(aripiprazole) Receives Expanded Indications for Maintenance Treatment in both Pediatric Patients(Aged 10-17) with Manic and Mixed Episodes of Bipolar I Disorder and Adolescents(Aged 13-17) with Schizophrenia
- 12 MAY 2008
U.S. Food and Drug Administration Approves Abilify®(aripiprazole) for Add-on Treatment to Lithium or Valproate in the Acute Treatment of Adults with Manic and Mixed Episodes of Bipolar I Disorder with or without Psychotic Features
- 25 APR 2008
The Otsuka Pharmaceutical Group – First time exhibitor at the Hannover Messe.
- 25 APR 2008
The rhythms of Japan – 50 dancers from Otsuka Pharmaceuticals perform the Awa Odori dance at the Hannover Messe Opening Ceremony.
- 25 APR 2008
The first drug to be approved in Sweden for intermittent claudication:Pletal® is reimbursed
- 09 APRIL 2008
Bristol-Myers Squibb and Otsuka Receive European Marketing Authorisation for Abilify® in the Treatment and Prevention of Moderate to Severe Manic Episodes in Bipolar I Disorder
- 12 MAR 2008
Otsuka Pharmaceutical and PDL Biopharma Close Sale of IV Busulfex
- 03 MAR 2008
U.S. Food and Drug Administration Approves Abilify®(aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated with Bipolar I Disorder in Pediatric Patients(10 to 17 Years of Age)
- 26 FEB 2008
Bristol-Myers Squibb and Otsuka Receive Positive CHMP Opinion for Abilify® (aripiprazole) in Bipolar I Disporder
2007
- 21 DEC 2007
New Drug Application for Tolvaptan, Otsuka's Investigational Novel Oral Treatment for Worsening Heart Failure and Hyponatremia, Accepted by The U.S. Food and Drug Administration
- 18 DEC 2007
Otsuka Pharmaceutical Acquires Rights to IV Busulfex from PDL Biopharma
- 21 NOV 2007
U.S. Food and Drug Administration Approves ABILIFY® (aripiprazole) as the First Medication for Add-On Treatment of Major Depressive Disorder (MDD)
- 9 JUL 2007
GW and Otsuka Enter into Global Cannabinoid Research Collaboration
- 26 JUN 2007
New Symbol Signifying Otsuka Pharmaceutical's Corporate Philosophy Introduced on June 26, 2007
- 25 JUN 2007
(PDF) Otsuka Pharmaceutical Co., Ltd.- Financial Results for the Year ended March 31, 2007
- 15 MAY 2007
SOYJOY Fruit Soy Bar launched in Taiwan by Otsuka Pharmaceutical affiliate, King Car Otsuka Co., Ltd.
- 24 APR 2007
The Pharmaceutical Society of Japan Award for Drug Research and Development '07 received for antipsychotic drug "aripiprazole"
- 10 APR 2007
Fruit Soy Bar SOYJOY launched nationwide in US by Otsuka Pharmaceutical subsidiary, Pharmavite LLC
- 14 FEB 2007
GW and Otsuka Announce Major Long Term Strategic Cannabinoid Alliance
- 24 JAN 2007
Otsuka Pharmaceutical Co., Ltd. Announces Establishment of New Organization
- 23 JAN 2007
Otsuka Pharmaceutical Co., Ltd Announces VV Food & Beverage Co., Ltd. Launches Fruits Soy Bar SOY JOY in China
- 5 JAN 2007
Otsuka Pharmaceutical Europe and Schwarz Pharma Deutschland to Co-promote Antiplatelet Agent Pletal® in Germany
Back to top